Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial

Journal of Clinical Oncology

Volumn 31, Issue 32, 2013, Pages 4054-4059

  Donker, Mila ^a   Litière, Saskia ^c   Werutsky, Gustavo ^c   Julien, Jean Pierre ^d   Fentiman, Ian S ^g   Agresti, Roberto ^h   Rouanet, Philippe ^e   De Lara, Christine Tunon ^f   Bartelink, Harry ^a   Duez, Nicole ^c   Rutgers, Emiel J T ^a   Bijker, Nina ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c EORTC DATA CENTER   (Belgium)

^d CENTRE HENRI BECQUEREL   (France)

^e Centre Régional de Lutte Contre le Cancer   (France)

^f INSTITUT BERGONIÉ   (France)

^g GUY S HOSPITAL   (United Kingdom)

^h NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LOCAL THERAPY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; RISK REDUCTION; SALVAGE THERAPY; TUMOR VOLUME; ADJUVANT THERAPY; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CLINICAL TRIAL; CONTROLLED STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM RECURRENCE, LOCAL; PHASE 3 CLINICAL TRIAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84891512298     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.5077     Document Type: Article

References (26)

1. Virnig BA, Tuttle TM, Shamliyan T, et al: Ductal carcinoma in situ of the breast: A systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst 102:170-178, 2010
2. Wapnir IL, Dignam JJ, Fisher B, et al: Longterm outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103:478-488, 2011
3. Holmberg L, Garmo H, Granstrand B, et al: Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26:1247-1252, 2008
4. Cuzick J, Sestak I, Pinder SE, et al: Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12:21-29, 2011
5. Julien JP, Bijker N, Fentiman IS, et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853-EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528-533, 2000
6. Bijker N, Meijnen P, Peterse JL, et al: Breastconserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24:3381-3387, 2006
7. Correa C, McGale P, Taylor C, et al: Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010:162-177, 2010
8. Bijker N, Peterse JL, Duchateau L, et al: Risk factors for recurrence and metastasis after breastconserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 19: 2263-2271, 2001
9. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
10. Collett D: Modelling Survival Data in Medical Research (ed 2). New York, NY, Chapman and Hall, 2003
11. Anderson JR, Cain KC, Gelber RD: Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. J Clin Oncol 26:3913-3915, 2008
12. Solin LJ, Fourquet A, Vicini FA, et al: Longterm outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer 103:1137-1146, 2005
13. Allred DC, Anderson SJ, Paik S, et al: Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: A study based on NSABP protocol B-24. J Clin Oncol 30:1268-1273, 2012
14. Chang MM, Huston T, Ascherman J, et al: Oncoplastic breast reduction: Maximizing aesthetics and surgical margins. Int J Surg Oncol 2012:907576, 2012
15. Millar EK, Leong AS: Significance and assessment of margin status in ductal carcinoma in situ of the breast. Adv Anat Pathol 8:338-344, 2001
16. Poortmans P, Aznar M, Bartelink H: Quality indicators for breast cancer: Revisiting historical evidence in the context of technology changes. Semin Radiat Oncol 22:29-39, 2012
17. Darby S, McGale P, Correa C, et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378:1707-1716, 2011
18. Berrington de Gonzalez A, Curtis RE, Gilbert E, et al: Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 102:220-226, 2010
19. Emdin SO, Granstrand B, Ringberg A, et al: SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast-Results of a randomised trial in a population offered mammography screening. Acta Oncol 45:536-543, 2006
20. Solin LJ, Fourquet A, Vicini FA, et al: Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. Eur J Cancer 41:1715-1723, 2005
21. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998
22. Cutuli B, Cohen-Solal-le Nir C, de Lafontan B, et al: Breast-conserving therapy for ductal carcinoma in situ of the breast: The French Cancer Centers' experience. Int J Radiat Oncol Biol Phys 53:868-879, 2002
23. Silverstein MJ, Lagios MD, Martino S, et al: Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 16:1367-1373, 1998
24. Romero L, Klein L, Ye W, et al: Outcome after invasive recurrence in patients with ductal carcinoma in situ of the breast. Am J Surg 188:371-376, 2004
25. Lee LA, Silverstein MJ, Chung CT, et al: Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast. Am J Surg 192:416-419, 2006
26. Voogd AC, van Oost FJ, Rutgers EJ, et al: Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 41:2637-2644, 2005